Search results for Sodium-Glucose Cotransporter-2

Latest updates for Sodium-Glucose Cotransporter-2

Fresh curated links around Sodium-Glucose Cotransporter-2 are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

kidney-international.org /4 weeks ago

Uncoupling glucosuria from infection: SGLT2 inhibition modulates kidney immune response during pyelonephritis

Sodium-glucose cotransporter 2 inhibitors increase urinary glucose excretion, theoretically predisposing to urinary tract infection, yet clinical trials have not shown higher rates...

Read source

bioengineer.org /1 month ago

SGLT2 Inhibitors Safe, Effective for Diabetes in Elderly

In a groundbreaking multi-center retrospective cohort study published in BMC Geriatrics, researchers have illuminated the nuanced effectiveness and safety profile of sodium-glucose...

Read source

healio.com /1 month ago

SGLT-2 inhibitors reduced hepatic decompensation in cirrhosis

Use of sodium-glucose cotransporter-2 inhibitors was linked to significantly reduced risk for adverse kidney, cardiovascular and hepatic outcomes in patients with type 2 diabetes a...

Read source

bioengineer.org /1 month ago

Urea-Activated Nanocarrier Targets Metabolic and Kidney Health

In the ever-advancing landscape of biomedical research, a groundbreaking study has emerged that could redefine therapeutic strategies for complex metabolic diseases, particularly t...

Read source

kidney-international.org /1 month ago

Obstructive renal Candida fungus balls in an SGLT2-inhibitor user

SGLT2-inhibitors use has increased exponentially following recommendations in international guidelines for their use in diabetes mellitus, heart failure and chronic kidney disease....

Read source

qchron.com /2 weeks ago

New Nature Communications Publication Highlights Efsubaglutide Alfa's Effects on Glycaemia and β-Cell Function

HONG KONG, May 12, 2026 /PRNewswire/ -- A major new clinical study, SUPER 2, has been published in Nature Communications, reporting that Efsubaglutide Alfa, a long-acting GLP-1 rec...

Read source

drugs.com /1 month ago

FDA Approves First Generic Farxiga (dapagliflozin) Tablets

April 7, 2026 -- The U.S. Food and Drug Administration approved the first generics of Farxiga (dapagliflozin) tablets to reduce the risk of hospitalization for heart failure in adu...

Read source

bioengineer.org /3 weeks ago

Efsubaglutide Alfa Boosts Glycaemia Control in T2D

In a groundbreaking stride toward advancing the therapeutic landscape for type 2 diabetes, a recent multicenter clinical trial has unveiled the promising efficacy of efsubaglutide...

Read source

bioengineer.org /1 month ago

Sodium Overload Drives Kidney Disease via Necrosis

In a groundbreaking study published in 2026, researchers have unveiled a compelling new mechanism linking sodium overload to necrosis in kidney cells, shedding light on the pathoph...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.